This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chyatte, D. Articles by Lewis, I. Search for Related Content PubMed PubMed Citation Articles by Chyatte, D. Articles by Lewis, I.

(Stroke. 1997;28:799-804.)
© 1997 American Heart Association, Inc.

Articles

Gelatinase Activity and the Occurrence of Cerebral Aneurysms

Douglas Chyatte, MD Isabel Lewis, BS

From the Cerebrovascular Research Laboratory, Section of Cerebrovascular Surgery, The Cleveland Clinic Foundation (Ohio).

Correspondence to Douglas Chyatte, MD, Section of Cerebrovascular Surgery, S80, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail chyattd{at}cesmtp.ccf.org

Background and Purpose Cerebral aneurysms are associated with decreased arterial collagen content; however, whether this deficiency results from impaired collagen synthesis or enhanced collagen degradation is unknown. This study tested the hypothesis that enhanced collagen degradation, not impaired collagen synthesis, is associated with the occurrence of cerebral aneurysms.

Methods Cultured skin fibroblasts and serum samples were studied in patients with angiographic evidence of aneurysm (n=31) and control subjects (n=14). Transcription of the type III collagen gene was assessed with the use of Northern blots prepared from RNA harvested from confluent cultured fibroblasts. Translation of type III collagen was assessed by Western blot analysis of proteins produced by cultured skin fibroblasts. Collagen metabolism was assessed by radioimmunoassay for type I (PICP) and type III (PIIINP) procollagen peptides in conditioned tissue culture media and serum. We assessed collagen degradation in serum and conditioned tissue culture media by evaluating gelatinase activity using quantitative zymography.

Results Type III collagen synthesis was the same in aneurysm and control patients. Neither the molecular weight nor the relative amount of type III collagen mRNA differed between aneurysm and control patient fibroblasts. Western blot analysis revealed no difference in the relative amount or molecular weight of procollagen III synthesized by aneurysm and control cells. Aneurysm patients had a threefold increase in native serum gelatinase activity compared with control subjects (P=.004). This increase occurred along with serum evidence of increased collagen metabolism. Serum levels of PICP (P=.03) and PIIINP (P=.02) were decreased in aneurysm patients. Elevated serum gelatinase activity and altered collagen metabolism could not be explained by enhanced secretion of gelatinase by cultured fibroblasts or altered net collagen synthesis by fibroblasts. High serum gelatinase activity was more common in men than in women (P=.04).

Conclusions These findings are consistent with the hypothesis that accelerated enzymatic degradation of collagens and other structural proteins compromises the mechanical integrity of the cerebral vessel wall and leads to conditions that favor aneurysm formation.

Key Words: cerebral aneurysm • collagen • gelatinases • subarachnoid hemorrhage

This article has been cited by other articles:

				Y. Nuki, T.-L. Tsou, C. Kurihara, M. Kanematsu, Y. Kanematsu, and T. Hashimoto Elastase-Induced Intracranial Aneurysms in Hypertensive Mice Hypertension, December 1, 2009; 54(6): 1337 - 1344. [Abstract] [Full Text] [PDF]

				H. Ohkuma, S. Suzuki, S. Fujita, and W. Nakamura Role of a Decreased Expression of the Local Renin-Angiotensin System in the Etiology of Cerebral Aneurysms Circulation, August 19, 2003; 108(7): 785 - 787. [Abstract] [Full Text] [PDF]

				T. Hashimoto, G. Wen, M. T. Lawton, N. J. Boudreau, A. W. Bollen, G.-Y. Yang, N. M. Barbaro, R. T. Higashida, C. F. Dowd, V. V. Halbach, et al. Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations * Growth and Bleeding in BAVM: Another Role for MMPs Stroke, April 1, 2003; 34(4): 925 - 931. [Abstract] [Full Text] [PDF]

				D. Krex, A. Ziegler, H. K. Schackert, and G. Schackert Lack of Association Between Endoglin Intron 7 Insertion Polymorphism and Intracranial Aneurysms in a White Population: Evidence of Racial/Ethnic Differences Stroke, November 1, 2001; 32(11): 2689 - 2694. [Abstract] [Full Text] [PDF]

				B. Guillon, C. Tzourio, V. Biousse, V. Adrai, M. G. Bousser, and P. J. Touboul Arterial wall properties in carotid artery dissection: An ultrasound study Neurology, September 12, 2000; 55(5): 663 - 666. [Abstract] [Full Text] [PDF]

				D. G. Peters, A. Kassam, P. L. St. Jean, H. Yonas, and R. E. Ferrell Functional Polymorphism in the Matrix Metalloproteinase-9 Promoter as a Potential Risk Factor for Intracranial Aneurysm Stroke, December 1, 1999; 30(12): 2612 - 2616. [Abstract] [Full Text] [PDF]

				J. S. P. van den Berg, G. Pals, F. Arwert, R. C. M. Hennekam, K. W. Albrecht, A. Westerveld, and M. Limburg Type III Collagen Deficiency in Saccular Intracranial Aneurysms : Defect in Gene Regulation? Stroke, August 1, 1999; 30(8): 1628 - 1631. [Abstract] [Full Text] [PDF]

				D. R. Todor, I. Lewis, G. Bruno, and D. Chyatte Identification of a Serum Gelatinase Associated With the Occurrence of Cerebral Aneurysms as Pro-Matrix Metalloproteinase-2 Stroke, August 1, 1998; 29(8): 1580 - 1583. [Abstract] [Full Text] [PDF]